UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Quantitative Evaluation of Mechanosensing of Cells on Dynamically Tunable Hydrogels

Journal of the American Chemical Society, 2011-02, Vol.133 (5), p.1367-1374

2011

Volltextzugriff (PDF)

3D Cellular Architecture Modulates Tyrosine Kinase Activity, Thereby Switching CD95-Mediated Apoptosis to Survival

Cell reports (Cambridge), 2019-11, Vol.29 (8), p.2295-2306.e6

2019

Volltextzugriff (PDF)

Spatio-temporal patterns of pancreatic cancer cells expressing CD44 isoforms on supported membranes displaying hyaluronic acid oligomers arrays

PloS one, 2012-08, Vol.7 (8), p.e42991-e42991

2012

Volltextzugriff (PDF)

Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases

Journal of antimicrobial chemotherapy, 2019-03, Vol.74 (3), p.761-767

2019

Volltextzugriff (PDF)

Supported Membranes Meet Flat Fluidics: Monitoring Dynamic Cell Adhesion on Pump-Free Microfluidics Chips Functionalized with Supported Membranes Displaying Mannose Domains

Materials, 2013-02, Vol.6 (2), p.669-681

2013

Volltextzugriff (PDF)

Waveguide for air-coupled ultrasonic phased-arrays with propagation time compensation and plug-in assembly

The Journal of the Acoustical Society of America, 2021-11, Vol.150 (5), p.3228-3237

2021

Volltextzugriff (PDF)

Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study

Investigational new drugs, 2023-04, Vol.41 (2), p.267-275

2023

Volltextzugriff (PDF)

Lisavanbulin (BAL101553), a novel, oral microtubule destabilizer plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma: A phase 1 Adult Brain Tumor Consortium study (ABTC1601)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2058-2058

2023

Volltextzugriff (PDF)

Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2044-2044

2023

Volltextzugriff (PDF)

The potential utility of end-binding protein 1 (EB1) as response-predictive biomarker for lisavanbulin: A phase 2 study of lisavanbulin (BAL101553) in adult patients with recurrent glioblastoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS2068-TPS2068

2021

Volltextzugriff (PDF)

Expression of end-binding protein 1 (EB1), a potential response-predictive biomarker for lisavanbulin, in glioblastoma and various other solid tumor types

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3118-3118

2021

Volltextzugriff (PDF)

Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours

British journal of cancer, 2020-10, Vol.123 (9), p.1360-1369

2020

Volltextzugriff (PDF)

A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors

Investigational new drugs, 2020-08, Vol.38 (4), p.1067-1076

2020

Volltextzugriff (PDF)

Phase 1/2a study of once daily oral BAL101553, a novel tumor checkpoint controller (TCC), in adult patients with progressive or recurrent glioblastoma (GBM) or high-grade glioma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2025-2025

2019

Volltextzugriff (PDF)

Phase 1/2a study of BAL101553, a novel tumor checkpoint controller (TCC), administered as 48-hour infusion in adult patients with advanced solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2529-2529

2018

Volltextzugriff (PDF)

Phase 1/2a study of once daily oral BAL101553, a novel tumor checkpoint controller (TCC), in adult patients with advanced solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2530-2530

2018

Volltextzugriff (PDF)

Modulation of Band Bending of Gallium Arsenide with Oriented Helical Peptide Monolayers

Journal of physical chemistry. C, 2010-12, Vol.114 (51), p.22677-22683

2010

Volltextzugriff (PDF)

Control of specific cell response with strongly correlated functional domains embedded in supported membranes

Kaindl, Thomas

2011

Volltextzugriff (PDF)

A compact acoustic waveguide for air-coupled ultrasonic phased arrays at 40 kHz

2022 IEEE International Ultrasonics Symposium (IUS), 2022, p.1-4

2022

Volltextzugriff (PDF)

Wave propagation in an acoustic waveguide for ultrasonic phased arrays

2019 IEEE International Ultrasonics Symposium (IUS), 2019, p.796-799

2019

Volltextzugriff (PDF)

Homozygous YME1L1 mutation causes mitochondriopathy with optic atrophy and mitochondrial network fragmentation

eLife, 2016-08, Vol.5

2016

Volltextzugriff (PDF)

Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta

Stem cell reports, 2018-08, Vol.11 (2), p.537-551

2018

Volltextzugriff (PDF)

Estrogen Signaling Drives Ciliogenesis in Human Endometrial Organoids

Endocrinology (Philadelphia), 2019-10, Vol.160 (10), p.2282-2297

2019

Volltextzugriff (PDF)

Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system

Nature communications, 2015-04, Vol.6 (1), p.6761, Article 6761

2015

Volltextzugriff (PDF)

Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate

Frontiers in neurology, 2022-07, Vol.13, p.950171-950171

2022

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Englisch
(100)
Japanisch
(12)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Technology
(30)
Life Sciences & Biomedicine
(29)
Humans
(22)
Physical Sciences
(18)
Female
(17)
Physics
(14)
Materials Science
(13)
Chemistry
(10)
Computer Science
(10)
Engineering
(9)
Male
(9)
Materials Science, Multidisciplinary
(9)
Mutation
(9)
Computer Science, Theory & Methods
(8)
Neurosciences
(8)
Patients
(8)
Physics, Applied
(8)
Animals
(7)
Chemistry, Physical
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantitative Evaluation of Mechanosensing of Cells on Dynamically Tunable Hydrogels

3D Cellular Architecture Modulates Tyrosine Kinase Activity, Thereby Switching CD95-Mediated Apoptosis to Survival

Spatio-temporal patterns of pancreatic cancer cells expressing CD44 isoforms on supported membranes displaying hyaluronic acid oligomers arrays

Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases

Supported Membranes Meet Flat Fluidics: Monitoring Dynamic Cell Adhesion on Pump-Free Microfluidics Chips Functionalized with Supported Membranes Displaying Mannose Domains

Waveguide for air-coupled ultrasonic phased-arrays with propagation time compensation and plug-in assembly

Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study

Lisavanbulin (BAL101553), a novel, oral microtubule destabilizer plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma: A phase 1 Adult Brain Tumor Consortium study (ABTC1601)

Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers

The potential utility of end-binding protein 1 (EB1) as response-predictive biomarker for lisavanbulin: A phase 2 study of lisavanbulin (BAL101553) in adult patients with recurrent glioblastoma

Expression of end-binding protein 1 (EB1), a potential response-predictive biomarker for lisavanbulin, in glioblastoma and various other solid tumor types

Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours

A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors

Phase 1/2a study of once daily oral BAL101553, a novel tumor checkpoint controller (TCC), in adult patients with progressive or recurrent glioblastoma (GBM) or high-grade glioma

Phase 1/2a study of BAL101553, a novel tumor checkpoint controller (TCC), administered as 48-hour infusion in adult patients with advanced solid tumors

Phase 1/2a study of once daily oral BAL101553, a novel tumor checkpoint controller (TCC), in adult patients with advanced solid tumors

Modulation of Band Bending of Gallium Arsenide with Oriented Helical Peptide Monolayers

Control of specific cell response with strongly correlated functional domains embedded in supported membranes

A compact acoustic waveguide for air-coupled ultrasonic phased arrays at 40 kHz

Wave propagation in an acoustic waveguide for ultrasonic phased arrays

Homozygous YME1L1 mutation causes mitochondriopathy with optic atrophy and mitochondrial network fragmentation

Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta

Estrogen Signaling Drives Ciliogenesis in Human Endometrial Organoids

Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system

Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate

Suchergebnisse filtern